R
Ron Pisters
Researcher at Maastricht University Medical Centre
Publications - 83
Citations - 12119
Ron Pisters is an academic researcher from Maastricht University Medical Centre. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 24, co-authored 67 publications receiving 10515 citations. Previous affiliations of Ron Pisters include Maastricht University & University of Birmingham.
Papers
More filters
Journal ArticleDOI
On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation.
Astrid N L Hermans,Rachel M J van der Velden,Monika Gawalko,Dominique V M Verhaert,Dominique V M Verhaert,Lien Desteghe,David Duncker,Martin Manninger,Hein Heidbuchel,Ron Pisters,Martin E.W. Hemels,Laurent Pison,Afzal Sohaib,Arian Sultan,Daniel Steven,Petra Wijtvliet,Robert G. Tieleman,Dhiraj Gupta,Dobromir Dobrev,Emma Svennberg,Harry J.G.M. Crijns,Nikki A H A Pluymaekers,Jeroen M.L. Hendriks,Jeroen M.L. Hendriks,Dominik Linz,TeleCheck-AF investigators +25 more
TL;DR: Teleconsultation solutions can deliver remote situations that are relatively similar to face‐to‐face interaction but remote assessment of heart rate and rhythm as well as risk factors remains challenging in patients with atrial fibrillation.
Journal ArticleDOI
Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial.
Ron Pisters,Stefan H. Hohnloser,Stuart J. Connolly,Christian Torp-Pedersen,Lisa Naditch-Brûlé,Richard L. Page,Harry J.G.M. Crijns +6 more
TL;DR: Dronedarone on top of standard care in AF patients with CHD reduced cardiovascular hospitalization or death similar to that in the overall ATHENA population, and reduced a first acute coronary syndrome.
Journal ArticleDOI
Clinical and echocardiographic correlates of intra-atrial conduction delay
Bob Weijs,Cees B. de Vos,Robert G. Tieleman,Ron Pisters,Emile C. Cheriex,Martin H. Prins,Harry J.G.M. Crijns +6 more
TL;DR: It is found that the PA-TDI was independently prolonged in patients with a history of AF, hypertension, valve disease, higher age, and a higher BMI, suggesting that early and aggressive treatment of hypertension, diastolic dysfunction, and obesity could prevent intra-atrial conduction delay.
Journal ArticleDOI
The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation
Bob Weijs,C B De Vos,Robert G. Tieleman,Frederique E C M Peeters,Ione Limantoro,Abraham A. Kroon,Emile C. Cheriex,Ron Pisters,Harry J.G.M. Crijns +8 more
TL;DR: Patients originally diagnosed with idiopathic AF develop CVD more often, at younger age, and with a more severe disease profile compared with healthy sinus rhythm control patients, suggesting the detection and treatment of CVD in an early stage could improve the prognosis of these patients.
Journal ArticleDOI
Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry
Ron Pisters,S. P. G. van Vugt,Marc A. Brouwer,Arif Elvan,W. L. ten Holt,P. A. G. Zwart,Paulus Kirchhof,Harry J.G.M. Crijns,Martin E.W. Hemels +8 more
TL;DR: In the Dutch subset of the XANTUS registry, low rates of major bleeding and label-discordant dosing and high persistence rates during one year of follow-up in patients receiving rivaroxaban in routine clinical practice are observed.